(Reuters) - Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback ...

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...

RedHill Biopharma (RDHL) announced the initiation of a Phase 2 clinical study to evaluate the efficacy of its opaganib candidate in combination ...

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...

German stocks are a bit volatile Tuesday morning with investors focusing on earnings and awaiting fresh economic data this week for ...

Crisil Coalition Greenwich today announced the 2025 Best Bank and Share Leader award winners. Over 60 banks were recognized ...

Austrian doctors are no longer allowed to fax. Patients have to wait while USB sticks drive cabs and ambulances deliver ...

LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce the ...